These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 16138582)

  • 1. [Advances in researches on the relationship between single nucleotide polymorphism and prostate cancer].
    Wang SK; Wang ZZ; Huang YF
    Zhonghua Nan Ke Xue; 2005 Aug; 11(8):605-10. PubMed ID: 16138582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genetic polymorphisms of susceptible genes associated with prostate cancer].
    Liu Y; Xu Y
    Zhonghua Nan Ke Xue; 2010 Jul; 16(7):651-5. PubMed ID: 20873603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interaction of four genes in the inflammation pathway significantly predicts prostate cancer risk.
    Xu J; Lowey J; Wiklund F; Sun J; Lindmark F; Hsu FC; Dimitrov L; Chang B; Turner AR; Liu W; Adami HO; Suh E; Moore JH; Zheng SL; Isaacs WB; Trent JM; Grönberg H
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2563-8. PubMed ID: 16284379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate-specific antigen mRNA and protein levels in laser microdissected cells of human prostate measured by real-time reverse transcriptase-quantitative polymerase chain reaction and immuno-quantitative polymerase chain reaction.
    Pinzani P; Lind K; Malentacchi F; Nesi G; Salvianti F; Villari D; Kubista M; Pazzagli M; Orlando C
    Hum Pathol; 2008 Oct; 39(10):1474-82. PubMed ID: 18619642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A G/A polymorphism in the androgen response element 1 of prostate-specific antigen gene correlates with the response to androgen deprivation therapy in Japanese population.
    Shibahara T; Onishi T; Franco OE; Arima K; Nishikawa K; Yanagawa M; Hioki T; Watanabe M; Hirokawa Y; Shiraishi T; Sugimura Y
    Anticancer Res; 2006; 26(5A):3365-71. PubMed ID: 17094454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genotype analysis of CYP1A2 IVS4 + 43A/G in patients with prostate cancer].
    Ge JP; Wei W; Shang XJ; Zhang ZY; Xu S; Wang D; Gao JP
    Zhonghua Nan Ke Xue; 2007 Nov; 13(11):1002-4. PubMed ID: 18077912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-2-microglobulin is an androgen-regulated secreted protein elevated in serum of patients with advanced prostate cancer.
    Gross M; Top I; Laux I; Katz J; Curran J; Tindell C; Agus D
    Clin Cancer Res; 2007 Apr; 13(7):1979-86. PubMed ID: 17404077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha 1 antichymotrypsin genotype is associated with increased risk of prostate carcinoma and PSA levels.
    Licastro F; Bertaccini A; Porcellini E; Chiappelli M; Pernetti R; Sanguedolce F; Marchiori D; Martorana G
    Anticancer Res; 2008; 28(1B):395-9. PubMed ID: 18383875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of multiple genetic polymorphisms on genitourinary morbidity after carbon ion radiotherapy for prostate cancer.
    Suga T; Iwakawa M; Tsuji H; Ishikawa H; Oda E; Noda S; Otsuka Y; Ishikawa A; Ishikawa K; Shimazaki J; Mizoe JE; Tsujii H; Imai T
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):808-13. PubMed ID: 18374504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PSA/KLK3 AREI promoter polymorphism alters androgen receptor binding and is associated with prostate cancer susceptibility.
    Lai J; Kedda MA; Hinze K; Smith RL; Yaxley J; Spurdle AB; Morris CP; Harris J; Clements JA
    Carcinogenesis; 2007 May; 28(5):1032-9. PubMed ID: 17151093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetic predisposition to prostate cancer].
    Jeanteur P
    Bull Cancer; 2008 Nov; 95(11):1063-6. PubMed ID: 19036678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular markers of prostate cancer.
    Bradford TJ; Tomlins SA; Wang X; Chinnaiyan AM
    Urol Oncol; 2006; 24(6):538-51. PubMed ID: 17138135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of incorporating genetic variants for the early detection of prostate cancer.
    Nam RK; Zhang WW; Trachtenberg J; Seth A; Klotz LH; Stanimirovic A; Punnen S; Venkateswaran V; Toi A; Loblaw DA; Sugar L; Siminovitch KA; Narod SA
    Clin Cancer Res; 2009 Mar; 15(5):1787-93. PubMed ID: 19223501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of genetic markers to determine risk for prostate cancer at prostate biopsy.
    Nam RK; Zhang WW; Jewett MA; Trachtenberg J; Klotz LH; Emami M; Sugar L; Sweet J; Toi A; Narod SA
    Clin Cancer Res; 2005 Dec; 11(23):8391-7. PubMed ID: 16322300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germ-line genetic variation in the key androgen-regulating genes androgen receptor, cytochrome P450, and steroid-5-alpha-reductase type 2 is important for prostate cancer development.
    Lindström S; Wiklund F; Adami HO; Bälter KA; Adolfsson J; Grönberg H
    Cancer Res; 2006 Nov; 66(22):11077-83. PubMed ID: 17108148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of genetic variability within 8q24 on aggressiveness patterns at diagnosis and familial status of prostate cancer.
    Cussenot O; Azzouzi AR; Bantsimba-Malanda G; Gaffory C; Mangin P; Cormier L; Fournier G; Valeri A; Jouffe L; Roupret M; Fromont G; Sibony M; Comperat E; Cancel-Tassin G
    Clin Cancer Res; 2008 Sep; 14(17):5635-9. PubMed ID: 18765558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Change of the cell cycle after flutamide treatment in prostate cancer cells and its molecular mechanism.
    Wang Y; Shao C; Shi CH; Zhang L; Yue HH; Wang PF; Yang B; Zhang YT; Liu F; Qin WJ; Wang H; Shao GX
    Asian J Androl; 2005 Dec; 7(4):375-80. PubMed ID: 16281084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advances in researches on single-nucleotide polymorphisms of candidate genes for type 2 diabetes].
    Liu Y; Liu Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Apr; 28(2):294-7. PubMed ID: 16733923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New polymorphisms in the PSA promoter in patients with prostate carcinoma].
    Schostak M; Braun C; Krause H; Miller K; Kempkensteffen C; Hinz S; Strenziok R; Blana A; Schrader M
    Aktuelle Urol; 2007 Nov; 38(6):465-72. PubMed ID: 17987534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Polymorphism of metabolic gene and genetic susceptibility to prostate cancer].
    Guan TY; Li M; Na YQ
    Zhonghua Wai Ke Za Zhi; 2005 Nov; 43(22):1467-70. PubMed ID: 16318816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.